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Sir,
In a recent paper, Bucchi et al (2005) report that the risk of axillary
lymph node metastases for screening detected cancers is increasing
more rapidly than for clinically detected cancers even after
adjusting for other risk factors. They argue that overdiagnosis
may not explain their results. I believe that overdiagnosis actually
may explain their results.
Further, Bucchi et al claim there is ‘no published data support
on an inverse association between overdiagnosis and tumour size’.
Actually, there are a lot of recent papers on the association
between mammography screening and overdiagnosis of small
tumours (Olsen and Gotzsche, 2001); (Zahl et al, 2004). Most
recently, Joensuu et al (2004) reported an extremely high level of
length time bias in screening detected cancers in the Finnish
mammography screening programme.
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